about
JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expressionAge-related changes in the content of the C-terminal region of aggrecan in human articular cartilageThe primary structure of human cartilage link proteinThe primary structure of human cartilage link proteinStem cells in veterinary medicine--attempts at regenerating equine tendon after injuryImmunoglobulin fold and tandem repeat structures in proteoglycan N-terminal domains and link proteinMacrophage sub-populations and the lipoxin A4 receptor implicate active inflammation during equine tendon repairBeneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathyAge-related changes in the response of human articular cartilage to IL-1alpha and transforming growth factor-beta (TGF-beta): chondrocytes exhibit a diminished sensitivity to TGF-beta.Development of a monoclonal anti-ADAMTS-5 antibody that specifically blocks the interaction with LRP1.Lentiviral vector transduction of spermatozoa as a tool for the study of early development.Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilageInflamm-aging and arachadonic acid metabolite differences with stage of tendon diseasePhenotypic modulation of chondrocytes as a potential therapeutic target in osteoarthritis: a hypothesisAggrecan, aging and assembly in articular cartilage.Structural changes in cartilage and collagen studied by high temperature Raman spectroscopy.MMP-13 is constitutively produced in human chondrocytes and co-endocytosed with ADAMTS-5 and TIMP-3 by the endocytic receptor LRP1Proteomic analysis of tendon extracellular matrix reveals disease stage-specific fragmentation and differential cleavage of COMP (cartilage oligomeric matrix protein).Low density lipoprotein receptor-related protein 1 (LRP1)-mediated endocytic clearance of a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4): functional differences of non-catalytic domains of ADAMTS-4 and ADAMTS-5 in LRP1 bResolving an inflammatory concept: the importance of inflammation and resolution in tendinopathy.Detection of cartilage matrix degradation by autofluorescence lifetime.Increased cartilage oligomeric matrix protein concentrations in equine digital flexor tendon sheath synovial fluid predicts intrathecal tendon damage.Exposure of a tendon extracellular matrix to synovial fluid triggers endogenous and engrafted cell death: A mechanism for failed healing of intrathecal tendon injuries.Quantification of aggrecan and link-protein mRNA in human articular cartilage of different ages by competitive reverse transcriptase-PCR.Domain structure and sequence similarities in cartilage proteoglycan.Proteoglycans and catabolic products of proteoglycans present in ligament.Erratum to: Viability of equine mesenchymal stem cells during transport and implantation.Inhibition of Shedding of Low-Density Lipoprotein Receptor-Related Protein 1 Reverses Cartilage Matrix Degradation in Osteoarthritis.Age-related differences in prostaglandin E2 synthesis by equine cartilage explants and synoviocytes.Viability of equine mesenchymal stem cells during transport and implantation.Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells.In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy.Modification of the composition of articular cartilage collagen fibrils with increasing age.Expression of Sulf1 and Sulf2 in cartilage, bone and endochondral fracture healing.Investigating the Postmortem Molecular Biology of Cartilage and its Potential Forensic Applications.Influence of commonly used pharmaceutical agents on equine bone marrow-derived mesenchymal stem cell viability.Complete primary sequence of equine cartilage link protein deduced from complementary DNA.Circulating concentrations of a marker of type I collagen metabolism are associated with hypertrophic cardiomyopathy mutation status in ragdoll cats.Cryopreservation of canine cardiosphere-derived cells: Implications for clinical application.Immunophenotypic characterization of ovine mesenchymal stem cells.
P50
Q24316553-9225FF23-A70A-469D-8A81-B50E750AFC32Q24534182-FEDCD370-4920-44B3-8A3D-23E5AB5AA85DQ24614703-58713DFA-270C-429A-BE91-BF4E2E3F7FB1Q24616420-92161944-9509-449D-9249-DF6239478312Q28240335-F12643EA-F1B4-4ED1-82E0-D420C9E159EFQ28276945-EF7AF40C-3C45-4AF7-930E-C465A01FFC13Q28731852-5189DB5F-7DE6-4112-9CB2-77C038600366Q30448820-4EEFD2F9-73FA-4D80-85E2-C46290C5D14EQ30988218-097365F4-BC6C-49B9-9AD4-63814EB51B86Q33641929-E8ADC321-63D8-44C5-8A84-A7FC5CB68FBBQ33724015-41DBDD2D-8B61-455C-AAD0-6EB33E79A551Q33728590-31693199-E7F2-4317-976D-13CF520D103DQ34479228-BCA5366C-A4D0-4064-A38A-DE254DB564CAQ35547255-7006EC46-F739-45C3-9CA8-237B7B1E69F6Q36249555-3B20D98C-58C8-420B-A429-46431D8D5673Q36287155-AE83DCDF-16A0-4DA7-9FD3-E2A2F606E121Q37488265-45E4DE43-4FA5-4EDD-AC9D-AC30CB87A6E0Q37596343-572E54D8-3037-4FFD-BC4B-97A13C6FDB86Q37622540-8E4CE031-823E-4C20-9836-8B0BC796FFDFQ37710454-440F5595-6850-4D55-9656-3D15AFD8E91AQ39498219-044AB108-7F3D-426E-BAB1-240C4D00F85FQ39958869-F7199E5A-D9A3-491C-BC6A-972208AD9421Q40411725-12AC8503-E8BA-4129-9B85-BB80D1FDCEDEQ41872014-B25CB862-49B4-4A93-80FB-C242F4282825Q41873679-8CBC20D2-9B9A-494D-91E6-42797F68FDCFQ42103945-73E56B37-1340-4024-8A2C-FAA3F29AB7DFQ42370935-FC9E4C52-E256-460B-AE9F-F1926FABF06EQ42881603-C5725046-C306-4C90-8BAD-B83D63627B44Q43014850-DEDBF836-3F2B-45F9-AF0A-EF3756D5EBE1Q43043807-9D1625BD-0BA0-4827-8B2F-D495DE58560CQ43743920-8D87C8EB-90C0-4D7C-8678-D7618A85D1A7Q45939031-181DEA32-8D80-43F8-B885-919544104474Q46259243-DBEF73AD-57F5-4927-AAB6-E6D7DFEAC622Q46279738-9DFD0E1C-059F-473A-88EE-D113DA6EF539Q46751210-238E882F-768A-4F4E-9898-7B6741680796Q47432788-E4BC2EB2-E390-426A-A558-E98B60FD2F09Q48072620-3C01FF96-F45A-49A1-B8E1-14B6A739F881Q48232087-571C0BDA-FE6C-46FC-A4B0-579EFB19E703Q48601122-E8743AB1-CE4C-4CFF-B615-1853A024004CQ48827577-0F73E9A8-A299-4CA5-9983-BCCC79F7F5F6
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jayesh Dudhia
@ast
Jayesh Dudhia
@en
Jayesh Dudhia
@es
Jayesh Dudhia
@nl
type
label
Jayesh Dudhia
@ast
Jayesh Dudhia
@en
Jayesh Dudhia
@es
Jayesh Dudhia
@nl
prefLabel
Jayesh Dudhia
@ast
Jayesh Dudhia
@en
Jayesh Dudhia
@es
Jayesh Dudhia
@nl
P106
P31
P496
0000-0002-2503-697X